| Irbesartan and diuretics |
№ ІІ- 12741/29.03.2011 |
CO-IRBESSO, Film coated tablet, 150 mg/ 12,5 mg, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените Лекарства АД -Пловдив, България |
25.9 |
5.18 |
31.08 |
6% |
1.55 |
27.45 |
5.49 |
32.94 |
18% |
4.66 |
32.11 |
6.42 |
38.53 |
|
КЦ-2493/26.07.2011 |
09.08.2011 |
09.08.2011 |
Неактивен |
1074 |
| Irbesartan and diuretics |
20110197 |
CO-IRBESSO, Film coated tablet, 300 mg/ 12,5 mg, -, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените Лекарства АД -Пловдив, България |
38.9 |
7.78 |
46.68 |
4% |
1.56 |
40.46 |
8.09 |
48.55 |
16% |
6.22 |
46.68 |
9.34 |
56.02 |
промяна на обстоятелства НСР-12991/15.06.2017 |
КЦ-2493/26.07.2011 |
09.08.2011 |
02.07.2017 |
Активен |
1075 |
| Irbesartan and diuretics |
№ ІІ- 12742/29.03.2011 |
CO-IRBESSO, Film coated tablet, 300 mg/ 12,5 mg, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма Висококачествените Лекарства АД -Пловдив, България |
38.9 |
7.78 |
46.68 |
4% |
1.56 |
40.46 |
8.09 |
48.55 |
16% |
6.22 |
46.68 |
9.34 |
56.02 |
|
КЦ-2493/26.07.2011 |
09.08.2011 |
09.08.2011 |
Неактивен |
1075 |
| Lisinopril, Hydrochlorothiazide |
20040199 |
Co-Linipril, Tablet, 20 mg/12,5 mg, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД |
6.45 |
1.29 |
7.74 |
7% |
0.45 |
6.9 |
1.38 |
8.28 |
20% |
1.29 |
8.19 |
1.64 |
9.83 |
|
НСР-1208/23.09.2013; КП-40/25.04.2019 и НСР-17695/10.01.2019 |
02.06.2019 |
02.06.2019 |
Активен |
2129 |
| Lisinopril, Hydrochlorothiazide |
20040199 |
Co-Linipril, Tablet, 20 mg/12,5 mg, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД |
6.63 |
1.33 |
7.96 |
7% |
0.46 |
7.09 |
1.42 |
8.51 |
20% |
1.33 |
8.42 |
1.68 |
10.1 |
|
НСР-1208/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2129 |
| Lisinopril, Hydrochlorothiazide |
20040198 |
Co-Linipril, Tablet, 10 mg/12,5 mg, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД |
6.63 |
1.33 |
7.96 |
7% |
0.46 |
7.09 |
1.42 |
8.51 |
20% |
1.33 |
8.42 |
1.68 |
10.1 |
|
НСР-1208/23.09.2013 |
11.10.2013 |
11.10.2013 |
Активен |
2128 |
| Lisinopril, Hydrochlorothiazide |
II-9094/17.03.2010 |
Co-Linipril, Tablet, 10 mg/12,5 mg, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД |
7 |
1.4 |
8.4 |
7% |
0.49 |
7.49 |
1.5 |
8.99 |
20% |
1.4 |
8.89 |
1.78 |
10.67 |
КЦ-1775/20.09.2010 ; КЦPP-1007/23.07.2012 промяна на обстоятелства |
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Неактивен |
2128 |
| Lisinopril, Hydrochlorothiazide |
II-5295/30.06.2009 |
Co-Linipril, Tablet, 20 mg/12,5 mg, mg, Pack: 30 |
Актавис EАД, България |
Actavis hf, Iceland: Actavis Ltd, Malta; Actavis UK Ltd., UK; Балканфарма – Дупница АД |
10.31 |
2.06 |
12.37 |
6% |
0.62 |
10.93 |
2.19 |
13.12 |
18% |
1.86 |
12.79 |
2.56 |
15.35 |
КЦ-1775/20.09.2010 ; КЦPP-1006/23.07.2012 промяна на обстоятелства |
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Неактивен |
2129 |
| Colistimethate sodium |
20170268 |
Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Дания |
59.22 |
11.84 |
71.06 |
4% |
2.37 |
61.59 |
12.32 |
73.91 |
16% |
9.48 |
71.07 |
14.21 |
85.28 |
Протокол №345/22.08.2019 |
НСР-19168/04.07.2019 |
19.07.2019 |
02.08.2019 |
Активен |
16608 |
| Colistimethate sodium |
20170268 |
Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Дания |
59.22 |
11.84 |
71.06 |
4% |
2.37 |
61.59 |
12.32 |
73.91 |
16% |
9.48 |
71.07 |
14.21 |
85.28 |
Протокол №345/22.08.2019 |
НСР-19168/04.07.2019 |
19.07.2019 |
02.08.2019 |
Неактивен |
16608 |
| Colistimethate sodium |
20170268 |
Colistin Alvogen, powder for solution for injection/infusion or inhalation, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Дания |
59.22 |
11.84 |
71.06 |
4% |
2.37 |
61.59 |
12.32 |
73.91 |
16% |
9.48 |
71.07 |
14.21 |
85.28 |
|
НСР-19168/04.07.2019 |
19.07.2019 |
02.08.2019 |
Неактивен |
16608 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
66.69 |
13.34 |
80.03 |
4% |
2.67 |
69.36 |
13.87 |
83.23 |
16% |
10.67 |
80.03 |
16.01 |
96.04 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018; КП-73/28.09.2018 и НСР-16485/17.08.2018;Протокол №345/22.08.2019 |
02.11.2018 |
02.11.2018 |
Активен |
3060 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
66.69 |
13.34 |
80.03 |
4% |
2.67 |
69.36 |
13.87 |
83.23 |
16% |
10.67 |
80.03 |
16.01 |
96.04 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018; КП-73/28.09.2018 и НСР-16485/17.08.2018 |
02.11.2018 |
02.11.2018 |
Неактивен |
3060 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
176.53 |
35.31 |
211.84 |
4% |
7.06 |
183.59 |
36.72 |
220.31 |
16% |
25 |
208.59 |
41.72 |
250.31 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017; АССГ № 2712/23.04.2018 и КП-45/19.06.2018 |
02.08.2018 |
02.08.2018 |
Неактивен |
3060 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
66.69 |
13.34 |
80.03 |
4% |
2.67 |
69.36 |
13.87 |
83.23 |
16% |
10.67 |
80.03 |
16.01 |
96.04 |
|
НСР-4253/30.07.2014; КП-58/25.07.2017 и НСР-12474/28.04.2017 |
02.09.2017 |
02.09.2017 |
Неактивен |
3060 |
| Colistimethate sodium |
20130167/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
106.71 |
21.34 |
128.05 |
4% |
4.27 |
110.98 |
22.2 |
133.18 |
16% |
17.07 |
128.05 |
25.61 |
153.66 |
|
НСР-1875/27.11.2013; КП-104/25.10.2017 и НСР-13346/28.07.2017; НСР-14654/18.12.2017 и НСР-14734/22.12.2017 (предварително изпълнение) |
02.12.2017 |
02.01.2018 |
Заличен |
2243 |
| Colistimethate sodium |
20130167/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
106.71 |
21.34 |
128.05 |
4% |
4.27 |
110.98 |
22.2 |
133.18 |
16% |
17.07 |
128.05 |
25.61 |
153.66 |
|
НСР-1875/27.11.2013; КП-104/25.10.2017 и НСР-13346/28.07.2017 |
02.12.2017 |
02.12.2017 |
Неактивен |
2243 |
| Colistimethate sodium |
20130167/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 2, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
449.84 |
89.97 |
539.81 |
4% |
10 |
459.84 |
91.97 |
551.81 |
16% |
25 |
484.84 |
96.97 |
581.81 |
|
НСР-1875/27.11.2013 |
28.11.2013 |
28.11.2013 |
Неактивен |
2243 |
| Colistimethate sodium |
20130166 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
176.53 |
35.31 |
211.84 |
4% |
7.06 |
183.59 |
36.72 |
220.31 |
16% |
25 |
208.59 |
41.72 |
250.31 |
|
НСР-4253/30.07.2014 |
13.08.2014 |
13.08.2014 |
Неактивен |
3060 |
| Colistimethate sodium |
20130166/13.05.2013 |
Colistin Alvogen, Powder for solution for injection/infusion, 1, MIU, Pack: 10 |
Alvogen IPCo S.àr.l, Люксембург |
Xellia Pharmaceuticals ApS, Dalslandsgade 11, DK-2300 Copenhagen S, Дания |
176.65 |
35.33 |
211.98 |
4% |
7.07 |
183.72 |
36.74 |
220.46 |
16% |
25 |
208.72 |
41.74 |
250.46 |
|
НСР-1875/27.11.2013 |
28.11.2013 |
28.11.2013 |
Неактивен |
3060 |
| Colistimethate sodium |
20170247 |
COLISTIN TZF, powder for solution for injection/infusion and inhalation, 1 000 000, IU, Pack: 20 |
Tarchomin Pharmaceutical Works "Polfa" S.A., Полша |
Tarchomin Pharmaceutical Works “Polfa” S.A., Полша |
118.46 |
23.69 |
142.15 |
4% |
4.74 |
123.2 |
24.64 |
147.84 |
16% |
18.95 |
142.15 |
28.43 |
170.58 |
Протокол №345/22.08.2019 |
НСР-17343/30.11.2018 |
15.12.2018 |
02.01.2019 |
Активен |
16363 |
| Colistimethate sodium |
20170247 |
COLISTIN TZF, powder for solution for injection/infusion and inhalation, 1 000 000, IU, Pack: 20 |
Tarchomin Pharmaceutical Works "Polfa" S.A., Полша |
Tarchomin Pharmaceutical Works “Polfa” S.A., Полша |
118.46 |
23.69 |
142.15 |
4% |
4.74 |
123.2 |
24.64 |
147.84 |
16% |
18.95 |
142.15 |
28.43 |
170.58 |
|
НСР-17343/30.11.2018 |
15.12.2018 |
02.01.2019 |
Неактивен |
16363 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), IU, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Teva B.V., Нидерландия |
Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018;Протокол №345/22.08.2019 |
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
02.01.2019 |
Активен |
4102 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), IU, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Teva B.V., Нидерландия |
Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018;Протокол №345/22.08.2019 |
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
02.01.2019 |
Неактивен |
4102 |
| Colistimethate sodium |
EU/1/11/747/001 |
Colobreathe, Inhalation powder, hard capsule, 1 662 500 IU (125 mg), -, Pack: 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
Teva B.V., Нидерландия |
Penn Pharmaceutical Services Ltd., Обединено кралство; Teva Pharmaceuticals Europe B.V., Нидерландия |
1645.03 |
329.01 |
1974.04 |
4% |
10 |
1655.03 |
331.01 |
1986.04 |
16% |
25 |
1680.03 |
336.01 |
2016.04 |
Промяна на обстоятелства НСР-12902/08.06.2017; НСР-17411/06.12.2018 |
НСР-7497/13.11.2015. (допуска се предварително изпълнение) |
13.11.2015 |
02.01.2019 |
Неактивен |
4102 |